Hematology TimesCAR T-cell therapy tested in SwedenSeptember 18, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersALLNon-Hodgkin LymphomaFollicular Lymphoma
Hematology NewsObinutuzumab trends better than rituxumab in relapsed indolent lymphomaSeptember 3, 2015Indolent LymphomaLymphoma & Plasma Cell DisordersFollicular Lymphoma
Hematology NewsLenalidomide + rituximab combo effective in recurrent follicular lymphomaAugust 24, 2015Indolent LymphomaLymphoma & Plasma Cell DisordersFollicular Lymphoma
Hematology TimesNew prognostic model for follicular lymphomaAugust 13, 2015Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaFollicular Lymphoma
Hematology NewsEarly follicular lymphoma progression signals poor outcomesJuly 24, 2015Aggressive LymphomasLymphoma & Plasma Cell DisordersFollicular Lymphoma
Hematology TimesPrenatal test results linked to cancer in mothersJuly 15, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersFollicular Lymphoma
Hematology TimesEarly progression predicts overall survival in FLJuly 9, 2015Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaFollicular Lymphoma
Hematology TimesNovel mAb targeting CD70 shows activity in TCLJuly 8, 2015Lymphoma & Plasma Cell DisordersHodgkin LymphomaNon-Hodgkin LymphomaFollicular Lymphoma
Hematology NewsSecond pathology review boosts diagnostic accuracy in lymphomaJuly 7, 2015Lymphoma & Plasma Cell DisordersIndolent LymphomaFollicular Lymphoma
Hematology NewsCUDC-907 passes early hurdle in heavily pretreated lymphoma, myelomaJuly 6, 2015Lymphoma & Plasma Cell DisordersAggressive LymphomasFollicular Lymphoma
Hematology TimesNovel SYK inhibitor shows ‘good early evidence’ of activityJuly 5, 2015Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaFollicular Lymphoma
Oncology PracticeEarly relapse signals high mortality in follicular lymphomaJuly 2, 2015Lymphoma & Plasma Cell DisordersIndolent LymphomaFollicular Lymphoma
Hematology Times‘Radically different’ PI3Kδ inhibitor lacks hepatotoxicityJune 30, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersHodgkin LymphomaNon-Hodgkin LymphomaFollicular Lymphoma
Oncology PracticeP13K inhibitors TGR-1202, duvelisib found clinically active in CLLJune 26, 2015Leukemia, Myelodysplasia, TransplantationFollicular Lymphoma
Hematology TimesTargeted agent shows early promise for NHLJune 25, 2015Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaFollicular Lymphoma
